Jinlei Liu

Title: Jinlei Liu: Innovator in Aminoquinazoline Derivatives

Introduction

Jinlei Liu is a prominent inventor based in Dongguan, China. He has made significant contributions to the field of medicine, particularly through his work on aminoquinazoline derivatives. With a total of 2 patents, his innovations are paving the way for advancements in pharmaceutical applications.

Latest Patents

Jinlei Liu's latest patents include "Aminoquinazoline derivatives and their salts and methods of use thereof." This invention provides aminoquinazoline compounds, salts, and their uses, focusing on preventing and managing proliferative disorders in patients. The compounds are designed to modulate protein tyrosine kinase activity, which is crucial for various cellular functions. Another notable patent is "Aminoquinazoline derivatives and their salts and methods of use." This invention relates to pharmaceutical formulations that are useful in modulating inter- and intra-cellular signaling, particularly in the treatment of hyperproliferative disorders in mammals, especially humans.

Career Highlights

Jinlei Liu is associated with Sunshine Lake Pharma Co., Ltd., where he continues to innovate and develop new pharmaceutical solutions. His work is instrumental in advancing medical treatments and improving patient outcomes.

Collaborations

Jinlei Liu collaborates with notable colleagues such as Jiancun Zhang and Yingjun Zhang. Their combined expertise contributes to the success of their projects and the development of new therapeutic approaches.

Conclusion

Jinlei Liu's contributions to the field of medicine through his patents on aminoquinazoline derivatives highlight his role as an influential inventor. His work not only advances scientific knowledge but also has the potential to improve healthcare outcomes for patients.